ProfileGDS4718 / 208407_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 98% 94% 99% 99% 95% 95% 98% 99% 99% 99% 99% 97% 95% 96% 98% 98% 97% 96% 92% 98% 98% 99% 98% 99% 97% 99% 97% 99% 97% 97% 93% 99% 99% 97% 96% 98% 98% 98% 92% 99% 97% 96% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.924498
GSM549102patient 115, normal, homogenized [OPG study]11.877998
GSM549104patient 119, normal, homogenized [OPG study]9.9907394
GSM549108patient 138, normal, homogenized [OPG study]11.929299
GSM549119patient 077, normal, homogenized [OPG study]12.17799
GSM549133patient 032, cancer, homogenized [OPG study]10.222695
GSM549139patient 042, cancer, homogenized [OPG study]10.307595
GSM549099patient 107, normal, homogenized [OPG study]11.823198
GSM549109patient 139, normal, homogenized [OPG study]12.0499
GSM549110patient 046, normal, homogenized [OPG study]12.199
GSM549114patient 063, normal, homogenized [OPG study]12.087799
GSM549122patient 082, normal, homogenized [OPG study]12.0299
GSM549134patient 033, cancer, homogenized [OPG study]10.800297
GSM549136patient 036, cancer, homogenized [OPG study]10.303895
GSM549140patient 044, cancer, homogenized [OPG study]10.373696
GSM549111patient 047, normal, homogenized [OPG study]11.601898
GSM549113patient 057, normal, homogenized [OPG study]11.96598
GSM549132patient 031, cancer, homogenized [OPG study]10.819597
GSM549137patient 038, cancer, homogenized [OPG study]10.293196
GSM549142patient 047, cancer, homogenized [OPG study]9.0715192
GSM549100patient 110, normal, homogenized [OPG study]11.832298
GSM549107patient 135, normal, homogenized [OPG study]11.933998
GSM549115patient 068, normal, homogenized [OPG study]12.074799
GSM549116patient 072, normal, homogenized [OPG study]11.958598
GSM549120patient 078, normal, homogenized [OPG study]11.948599
GSM549131patient 030, cancer, homogenized [OPG study]10.758897
GSM549118patient 074, normal, homogenized [OPG study]11.99199
GSM549129patient 027, cancer, homogenized [OPG study]10.607497
GSM549123patient 088, normal, homogenized [OPG study]11.956999
GSM549124patient 006, cancer, homogenized [OPG study]10.652197
GSM549126patient 015, cancer, homogenized [OPG study]11.002897
GSM549128patient 025, cancer, homogenized [OPG study]9.672493
GSM549103patient 117, normal, homogenized [OPG study]12.098799
GSM549117patient 073, normal, homogenized [OPG study]12.08399
GSM549138patient 041, cancer, homogenized [OPG study]10.72797
GSM549141patient 045, cancer, homogenized [OPG study]10.587296
GSM549130patient 028, cancer, homogenized [OPG study]10.928898
GSM549101patient 111, normal, homogenized [OPG study]11.646698
GSM549105patient 128, normal, homogenized [OPG study]11.873998
GSM549106patient 134, normal, homogenized [OPG study]9.7529992
GSM549112patient 048, normal, homogenized [OPG study]12.048799
GSM549125patient 011, cancer, homogenized [OPG study]10.697697
GSM549127patient 024, cancer, homogenized [OPG study]10.477596
GSM549135patient 035, cancer, homogenized [OPG study]10.126995